Long-chain omega 3 fatty acids: Molecular bases of potential antioxidant actions

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 90, Issue 1, 2014, Pages 1-4

  Giordano, Elena ^a   Visioli, Francesco ^a  

^a IMDEA FOOD INSTITUTE   (Spain)

Author keywords

Antioxidants; Cardiovascular disease; Free radicals; Polyunsaturated fatty acids

Indexed keywords

CATALASE; DOCOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID; LONG CHAIN FATTY ACID; OMEGA 3 FATTY ACID; PLACEBO; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL (TOPIC); DYSLIPIDEMIA; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPID PEROXIDATION; MILD COGNITIVE IMPAIRMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK REDUCTION;

ANTIOXIDANTS; CARDIOVASCULAR DISEASE; FREE RADICALS; POLYUNSATURATED FATTY ACIDS;

ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; FATTY ACIDS, OMEGA-3; HUMANS; INFLAMMATION; OXIDATIVE STRESS;

EID: 84891160114     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2013.11.002     Document Type: Article

References (52)

1. Jiang X., Yang Z., Chandrakala A.N., Pressley D., Parthasarathy S. Oxidized low density lipoproteins - do we know enough about them?. Cardiovasc. Drugs Ther. 2011, 25:367-377.
2. McNamara R.K., Strawn J.R. Role of long-chain omega-3 fatty acids in psychiatric practice. PharmaNutrition 2013, 1:41-49.
3. Visioli F. Pharma and nutrition: crossing the Rubicon. PharmaNutrition 2013, 1:9.
4. Visioli F., Galli C. Evaluating oxidation processes in relation to cardiovascular disease: a current review of oxidant/antioxidant methodology. Nutr. Metab. Cardiovasc. Dis. 1997, 7:459-466.
5. Garcia-Hernandez V.M., Gallar M., Sanchez-Soriano J., Micol V., Roche E., Garcia-Garcia E. Effect of omega-3 dietary supplements with different oxidation levels in the lipidic profile of women: a randomized controlled trial. Int. J. Food Sci. Nutr. 2013.
6. Albert B.B., Cameron-Smith D., Hofman P.L., Cutfield W.S. Oxidation of marine omega-3 supplements and human health. Biomed. Res. Int. 2013, 2013:464921.
7. Lonn M.E., Dennis J.M., Stocker R. Actions of "antioxidants" in the protection against atherosclerosis. Free Radic. Biol. Med. 2012, 53:863-884.
8. Niu X., Zammit V., Upston J.M., Dean R.T., Stocker R. Coexistence of oxidized lipids and alpha-tocopherol in all lipoprotein density fractions isolated from advanced human atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 1999, 19:1708-1718.
9. Halliwell B. Free radicals and antioxidants: updating a personal view. Nutr. Rev. 2012, 70:257-265.
10. Halliwell B. The wanderings of a free radical. Free Radic. Biol. Med. 2009, 46:531-542.
11. Ozkanlar S., Akcay F. Antioxidant vitamins in atherosclerosis--animal experiments and clinical studies. Adv. Clin. Exp. Med. 2012, 21:115-123.
12. Davidson M.H. Omega-3 fatty acids: new insights into the pharmacology and biology of docosahexaenoic acid, docosapentaenoic acid, and eicosapentaenoic acid. Curr. Opin. Lipidol. 2013.
13. Fenton J.I., Hord N.G., Ghosh S., Gurzell E.A. Immunomodulation by dietary long chain omega-3 fatty acids and the potential for adverse health outcomes. Prostaglandins Leukot. Essent. Fatty Acids 2013.
14. Davies S.S., Roberts L.J. F2-isoprostanes as an indicator and risk factor for coronary heart disease. Free Radic. Biol. Med. 2011, 50:559-566.
15. Halliwell B., Lee C.Y. Using isoprostanes as biomarkers of oxidative stress: some rarely considered issues. Antioxid. Redox. Signal. 2010, 13:145-156.
16. Higdon J.V., Du S.H., Lee Y.S., Wu T., Wander R.C. Supplementation of postmenopausal women with fish oil does not increase overall oxidation of LDL ex vivo compared to dietary oils rich in oleate and linoleate. J. Lipid Res. 2001, 42:407-418.
17. Higdon J.V., Liu J., Du S.H., Morrow J.D., Ames B.N., Wander R.C. Supplementation of postmenopausal women with fish oil rich in eicosapentaenoic acid and docosahexaenoic acid is not associated with greater in vivo lipid peroxidation compared with oils rich in oleate and linoleate as assessed by plasma malondialdehyde and F(2)-isoprostanes. Am. J. Clin. Nutr. 2000, 72:714-722.
18. Wander R.C., Du S.H. Oxidation of plasma proteins is not increased after supplementation with eicosapentaenoic and docosahexaenoic acids. Am. J. Clin. Nutr. 2000, 72:731-737.
19. Barden A.E., Mori T.A., Dunstan J.A., Taylor A.L., Thornton C.A., Croft K.D., Beilin L.J., Prescott S.L. Fish oil supplementation in pregnancy lowers F2-isoprostanes in neonates at high risk of atopy. Free Radic. Res. 2004, 38:233-239.
20. Jones M.L., Mark P.J., Mori T.A., Keelan J.A., Waddell B.J. Maternal dietary omega-3 fatty acid supplementation reduces placental oxidative stress and increases fetal and placental growth in the rat. Biol. Reprod. 2013, 88:37.
21. Mas E., Woodman R.J., Burke V., Puddey I.B., Beilin L.J., Durand T., Mori T.A. The omega-3 fatty acids EPA and DHA decrease plasma F(2)-isoprostanes: Results from two placebo-controlled interventions. Free Radic. Res. 2010, 44:983-990.
22. Mori T.A. Effect of fish and fish oil-derived omega-3 fatty acids on lipid oxidation. Redox Rep. 2004, 9:193-197.
23. Mori T.A., Dunstan D.W., Burke V., Croft K.D., Rivera J.H., Beilin L.J., Puddey I.B. Effect of dietary fish and exercise training on urinary F2-isoprostane excretion in non-insulin-dependent diabetic patients. Metabolism 1999, 48:1402-1408.
24. Driss F., Vericel E., Lagarde M., Dechavanne M., Darcet P. Inhibition of platelet aggregation and thromboxane synthesis after intake of small amount of icosapentaenoic acid. Thromb. Res. 1984, 36:389-396.
25. Guillot N., Caillet E., Laville M., Calzada C., Lagarde M., Vericel E. Increasing intakes of the long-chain omega-3 docosahexaenoic acid: effects on platelet functions and redox status in healthy men. FASEB J. 2009, 23:2909-2916.
26. Lagarde M., Croset M., Vericel E., Calzada C. Effects of small concentrations of eicosapentaenoic acid on platelets. J. Intern. Med. Suppl. 1989, 731:177-179.
27. Lee L.K., Shahar S., Rajab N., Yusoff N.A., Jamal R.A., Then S.M. The role of long chain omega-3 polyunsaturated fatty acids in reducing lipid peroxidation among elderly patients with mild cognitive impairment: a case-control study. J. Nutr. Biochem. 2013, 24:803-808.
28. Yavin E., Brand A., Green P. Docosahexaenoic acid abundance in the brain: a biodevice to combat oxidative stress. Nutr. Neurosci. 2002, 5:149-157.
29. Daak A.A., Ghebremeskel K., Mariniello K., Attallah B., Clough P., Elbashir M.I. Docosahexaenoic and eicosapentaenoic acid supplementation does not exacerbate oxidative stress or intravascular hemolysis in homozygous sickle cell patients. Prostaglandins Leukot. Essent. Fatty Acids 2013.
30. de Assis A.M., Rech A., Longoni A., Rotta L.N., Denardin C.C., Pasquali M.A., Souza D.O., Perry M.L., Moreira J.C. Omega3-Polyunsaturated fatty acids prevent lipoperoxidation, modulate antioxidant enzymes, and reduce lipid content but do not alter glycogen metabolism in the livers of diabetic rats fed on a high fat thermolyzed diet. Mol. Cell. Biochem. 2012, 361:151-160.
31. Lamaziere A., Wolf C., Barbe U., Bausero P., Visioli F. Lipidomics of hepatic lipogenesis inhibition by omega 3 fatty acids. Prostaglandins Leukot. Essent. Fatty Acids 2013, 88:149-154.
32. Visioli F., Colombo C., Galli C. Oxidation of individual fatty acids yields different profiles of oxidation markers. Biochem. Biophys. Res. Commun. 1998, 245:487-489.
33. Richard D., Kefi K., Barbe U., Bausero P., Visioli F. Polyunsaturated fatty acids as antioxidants. Pharmacol. Res. 2008, 57:451-455.
34. Casos K., Zaragoza M.C., Zarkovic N., Zarkovic K., Andrisic L., Portero-Otin M., Cacabelos D., Mitjavila M.T. A fish-oil-rich diet reduces vascular oxidative stress in apoE(-/-) mice. Free Radic. Res. 2010, 44:821-829.
35. Gortan Cappellari G., Losurdo P., Mazzucco S., Panizon E., Jevnicar M., Macaluso L., Fabris B., Barazzoni R., Biolo G., Carretta R., Zanetti M. Treatment with n-3 polyunsaturated fatty acids reverses endothelial dysfunction and oxidative stress in experimental menopause. J. Nutr. Biochem. 2013, 24:371-379.
36. Visioli F., Hagen T.M. Antioxidants to enhance fertility: role of eNOS and potential benefits. Pharmacol. Res. 2011, 64:431-437.
37. Stebbins C.L., Stice J.P., Hart C.M., Mbai F.N., Knowlton A.A. Effects of dietary decosahexaenoic acid (DHA) on eNOS in human coronary artery endothelial cells. J. Cardiovasc. Pharmacol. Ther. 2008, 13:261-268.
38. Richard D., Wolf C., Barbe U., Kefi K., Bausero P., Visioli F. Docosahexaenoic acid down-regulates endothelial Nox 4 through a sPLA2 signaling pathway. Biochem. Biophys. Res. Commun. 2009, 389:516-522.
39. Ago T., Kitazono T., Ooboshi H., Iyama T., Han Y.H., Takada J., Wakisaka M., Ibayashi S., Utsumi H., Iida M. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 2004, 109:227-233.
40. Rahman M., Kundu J.K., Shin J.W., Na H.K., Surh Y.J. Docosahexaenoic acid inhibits UVB-induced activation of NF-kappaB and expression of COX-2 and NOX-4 in HR-1 hairless mouse skin by blocking MSK1 signaling. PLoS ONE 2011, 6:e28065.
41. Kusunoki C., Yang L., Yoshizaki T., Nakagawa F., Ishikado A., Kondo M., Morino K., Sekine O., Ugi S., Nishio Y., Kashiwagi A., Maegawa H. Omega-3 polyunsaturated fatty acid has an anti-oxidant effect via the Nrf-2/HO-1 pathway in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 2013, 430:225-230.
42. Di Nunzio M., Valli V., Bordoni A. Pro- and anti-oxidant effects of polyunsaturated fatty acid supplementation in HepG2 cells. Prostaglandins Leukot. Essent. Fatty Acids 2011, 85:121-127.
43. Garrido A., Garrido F., Guerra R., Valenzuela A. Ingestion of high doses of fish oil increases the susceptibility of cellular membranes to the induction of oxidative stress. Lipids 1989, 24:833-835.
44. Tsuduki T., Honma T., Nakagawa K., Ikeda I., Miyazawa T. Long-term intake of fish oil increases oxidative stress and decreases lifespan in senescence-accelerated mice. Nutrition 2011, 27:334-337.
45. Nowak J.Z. Oxidative stress, polyunsaturated fatty acids-derived oxidation products and bisretinoids as potential inducers of CNS diseases: focus on age-related macular degeneration. Pharmacol Rep. 2013, 65:288-304.
46. Patten A.R., Brocardo P.S., Christie B.R. Omega-3 supplementation can restore glutathione levels and prevent oxidative damage caused by prenatal ethanol exposure. J. Nutr. Biochem. 2013, 24:760-769.
47. Massaro M., Basta G., Lazzerini G., Carluccio M.A., Bosetti F., Solaini G., Visioli F., Paolicchi A., De Caterina R. Quenching of intracellular ROS generation as a mechanism for oleate-induced reduction of endothelial activation and early atherogenesis. Thromb. Haemost. 2002, 88:335-344.
48. Smith W.L. Cyclooxygenases, peroxide tone and the allure of fish oil. Curr. Opin. Cell Biol. 2005, 17:174-182.
49. Musee J., Marnett L.J. Prostaglandin H synthase-2-catalyzed oxygenation of 2-arachidonoylglycerol is more sensitive to peroxide tone than oxygenation of arachidonic acid. J. Biol. Chem. 2012, 287:37383-37394.
50. Bolego C., Buccellati C., Prada A., Gaion R.M., Folco G., Sala A. Critical role of COX-1 in prostacyclin production by human endothelial cells under modification of hydroperoxide tone. FASEB J. 2009, 23:605-612.
51. Forman H.J., Davies K.J., Ursini F. How do nutritional antioxidants really work: Nucleophilic tone and para-hormesis versus free radical scavenging in vivo. Free Radic. Biol. Med. 2013.
52. Visioli F., Giordano E., Nicod N.M., Davalos A. Molecular targets of omega 3 and conjugated linoleic Fatty acids - "micromanaging" cellular response. Front Physiol. 2012, 3:42.